Teva Pharmaceutical Industries Limited Ordinary Shares (NY:TEVA)

39.53 +0.22 (+0.56%)

Official Closing Price Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Teva Pharmaceutical Industries Limited Ordinary Shares

< Previous 1 2

...

29 30 31 32 33 34 35 36 Next >

24 Stocks Moving in Tuesday's Pre-Market Session ↗

November 02, 2021

Gainers Baosheng Media Group Holdings Limited (NASDAQ: BAOS) rose 119% to $3.43 in pre-market trading after declining 3% on Monday. The company, last month, swung to a loss...

Via Benzinga

California Judge Rules That Teva Did Not Cause a Public Nuisance or Make False or Misleading Statements About Opioids

November 01, 2021

From Teva Pharmaceutical Industries Limited

Via Business Wire

Teva Reports Encouraging Data From Late-Stage Schizophrenia Trial ↗

November 01, 2021

Teva Pharmaceuticals Industries Ltd (NYSE: TEVA) announced results from the Phase 3 trial comparing TV-46000/mdc-IRM once monthly (q1m) and TV-46000/mdc-IRM once...

Via Benzinga

New Phase 3 Data Presented at Psych Congress 2021 Showed TV-46000/mdc-IRM Significantly Prolonged Time to Impending Relapse Compared to Placebo in Patients with Schizophrenia

October 30, 2021

From Teva Pharmaceutical Industries Limited

Via Business Wire

Earnings Scheduled For October 27, 2021 ↗

October 27, 2021

Companies Reporting Before The Bell • McDonald's (NYSE:MCD) is expected to report quarterly earnings at $2.46 per share on revenue of $6.03 billion. • General...

Via Benzinga

No Negative Reaction ↗

October 28, 2021

Today the impact of the Delta variant hit US GDP which was only 2% annualized, vs estimates of 2.6%, based on Q3 data which came out today.

Via Talk Markets

Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2021 ↗

October 28, 2021

Upgrades For Boot Barn Holdings Inc (NYSE:

Via Benzinga

Teva Pharmaceutical Industries (TEVA) Q3 2021 Earnings Call Transcript ↗

October 28, 2021

TEVA earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Why Teva Pharmaceutical Industries Fell Today ↗

October 27, 2021

The pharmaceutical giant whiffs on both the top and bottom lines in its Q3.

Via The Motley Fool

Looking Into Teva Pharmaceutical Indus's Return On Capital Employed ↗

October 27, 2021

Pulled from Benzinga Pro data, Teva Pharmaceutical Indus (NYSE:TEVA) posted Q3 earnings of $623.00 million, an increase from Q2 of 7.04%. Sales dropped to $3.89 billion, a 0.59%...

Via Benzinga

Teva Q3 Earnings Fall Short Of Expectations; Reaffirms FY21 Guidance ↗

October 27, 2021

Teva Pharmaceutical Industries Ltd's (NYSE: TEVA) Q3 sales reached $3.89 billion, shrinking 2% Y/Y or 3% in local currency terms, missing the consensus of $4.03...

Via Benzinga

Teva Stock Dips As The Sales Downfall Continues For Its Biggest Product ↗

October 27, 2021

Teva's multiple sclerosis treatment, Copaxone, is facing generic competition.

Via Investor's Business Daily

Teva Announces $3,500,000,000 Debt Tender Offers for Notes Due 2022-2024

October 27, 2021

From Teva Pharmaceutical Industries Limited

Via Business Wire

Teva Announces Launch of $4,000,000,000 Offering of Sustainability-linked Senior Notes

October 27, 2021

From Teva Pharmaceutical Industries Limited

Via Business Wire

Teva Reports Third Quarter 2021 Financial Results

October 27, 2021

From Teva Pharmaceutical Industries Limited

Via Business Wire

Tuesday Market Coverage ↗

October 26, 2021

Thermo Electron fell on the publication of its social responsibility report today.

Via Talk Markets

Teva and MODAG Announce Licensing Collaboration for Neurodegenerative Disease Drug Candidate

October 26, 2021

From Teva Pharmaceutical Industries Limited

Via Business Wire

Teva to Present New Data from Growing Mental Health Portfolio at Psych Congress 2021

October 21, 2021

From Teva Pharmaceutical Industries Limited

Via Business Wire

Wednesday Market Coverage ↗

October 20, 2021

Today gold rose again despite the active market for bitcoin and the lower Chinese demand for mine products like iron and coal.

Via Talk Markets

Bitcoin Futures Arrive ↗

October 19, 2021

Today you can finally hold Bitcoins via an exchange-traded fund.

Via Talk Markets

Is This The Most Exciting Medical Breakthrough Of The Decade

October 19, 2021

FN Media Group Presents Oilprice.com Market Commentary London – October 19, 2021 – According to Google’s Health boss David Feinberg… over one billion people a day search Google for health concerns....

Via FinancialNewsMedia

Chinese Growth Level ↗

October 18, 2021

The hot news today was a much weaker Chinese growth level this year, of 4.9% because of supply chain issues.

Via Talk Markets

More Chinese Trouble ↗

October 14, 2021

A day after the consumer price rise there was another price rise for producer markets.

Via Talk Markets

Friday Market Coverage ↗

October 08, 2021

New hiring again failed to rise in Sept., the 2nd month in a row which may be good news because it could delay the Fed tapering.

Via Talk Markets

Topics Economy

10 Health Care Stocks With Unusual Options Alerts In Today's Session ↗

October 08, 2021

This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the market estimation of an option...

Via Benzinga

Markets Boosted ↗

October 07, 2021

Good news helped stock prices.

Via Talk Markets

Perfumes Of Arabia ↗

October 06, 2021

Downtrends do eventually run out of pessimistic steam, but it can take a while.

Via Talk Markets

Bitcoin Is The Ferrari And Gold Is The Horse And Buggy, According To Bill Miller ↗

October 06, 2021

Legendary value investor Bill Miller remains bullish on Bitcoin (CRYPTO:

Via Benzinga

Biohaven Surges To Record High As Kardashian-Backed Migraine Drug Outperforms — Again ↗

October 05, 2021

This company sells a migraine medicine backed by Khloe Kardashian.

Via Investor's Business Daily

Teva Stops Production At U.S. Plant After FDA Concerns: Reports ↗

October 04, 2021

Teva Pharmaceutical Industries Ltd (NYSE: TEVA) has temporarily stopped drug production at its Irvine plant in California to address issues raised by the FDA after...

Via Benzinga

< Previous 1 2

...

29 30 31 32 33 34 35 36 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.